Activ Surgical Raises $15 Million To Advance Autonomous and Collaborative Robotic Surgery

Armory Raises $40M to Drive Software Delivery SaaS Platform for Enterprises Adopting Cloud

Exo imaging Secures $40 Million in Series B+ Funding to Advance Handheld Medical Imaging

Evonetix Raises $30 Million to Accelerate Internal Technology Development

Aspect Biosystems Announces $20 Million Series A Financing to Advance its Leading Platform for 3D Bioprinting of Human Tissue

CryptoKitties Maker Dapper Labs Raises $11 Million to Build a Blockchain for Gaming and Entertainment

Molecular Assemblies Announces $12.2 Million in Funding to Advance Enzymatic DNA Synthesis for Life Sciences and Data Storage

Immersv Raises $10.5 Million to Shake-up Mobile Advertising with Some VR Flair

Teampay Raises $12 Million in Funding to Further Leverage Breakthroughs in Natural Language

Meet our companies

We focus on vertical markets with high impact

Artificial Intelligence

Human-Centered
Machine Learning
Financial Technology
Natural Language Processing
Robotics

Blockchain

Capital Markets & Financial Services
Cryptoassets
Developer Tools
Storage, Security & Regulatory
Value Exchange

Deep Tech

Advanced Materials
Biotechnology
Cloud & Quantum Computing
Connected Transportation
Industry 4.0 Manufacturing

Healthcare

Bioinformatics
Digital Health
Genomics
Medical Devices
Personalized Medicine

MARKET FOCUS

10
Nov

Atia Vision Accelerating the Development of Intraocular Lens for the Ophthalmology Market

By Brent MacDonald

By Brent MacDonald – Principal @ Rising Tide VC Millions of people worldwide are visually impaired due to cataracts – loss of vision due to lens clouding. The two current treatment options, the standard intraocular lens (IOL) and multi-focal IOL, force patients to choose between focusing ability and clear vision. Current treatment options have limitations […]

02
Nov

Our Investment in Enzymatic DNA Synthesis Technology Capable of Powering New Products in Industrial Synthetic Biology, Personalized Therapeutics, Precision Diagnostics, and Eventually Information Storage, Nanotechnology and More

By Brent MacDonald

By Brent MacDonald – Principal @ Rising Tide VC Molecular Assemblies began more than 30 years ago when Bill Efcavitch and Curt Becker, then early founders at the pioneering biotech company Applied Biosystems, commercialized the first practical method of synthesizing DNA. Known as phosphoramidite synthesis[1], this chemical-based method was a significant breakthrough and remains the […]

26
Oct

Our Investment in Rebate Management Software – Enable Maximizes the Performance of B2B Deals While Improving Financial Transparency and Operational Efficiency

By Brent MacDonald

By Brent MacDonald – Principal @ Rising Tide VC Enable was born out of DCS Group, the largest distributor of health, beauty, and household products in the UK. DCS wanted a smart, efficient way to manage its many complex trading agreements with suppliers and customers. But it could not find a single solution that met […]

08
Sep

Silicon Valley and Korean Leaders to Launch a Sustainable and Innovation Business Forum to Connect the World’s Most Dynamic Regions

By Brent McDonald

SILICON VALLEY AND SEOUL, September 8, 2020. Silicon Valley leaders will launch a business forum to team up with Korean entrepreneurs, venture capitalist and innovators to jointly address the challenges and opportunities in a post-COVID global environment. The Silicon Valley Business Forum (SVBF) will take place from September 16-19th, 2020. The 3-day virtual event, kicked […]

25
Aug

Our Investment in High-Performance Handheld Ultrasound – Exo Raises $40 Million To Bring Diagnostic-Grade Medical Imaging to the Pocket of Every Caregiver and Clinician Worldwide

By Brent MacDonald

By Brent MacDonald – Principal @ Rising Tide VC Medical imaging for all — it’s a clarion call for change that grows louder every day. It comes from patients seeking greater access to imaging that will help them live healthier lives. It comes from families seeking answers as to why their children are sick. It comes from […]

19
Aug

Our Investment in Transformative Medicines – PNI is a global leader in technology and solutions for developing RNA, DNA, CRISPR, small molecule drugs, COVID vaccines and therapeutics

By Brent MacDonald

By Brent MacDonald – Principal @ Rising Tide VC Precision Nanosystems Inc’s (PNI) mission is to accelerate the creation of transformative medicine that significantly impacts human well being. The Company creates end-to-end solutions that empower researchers to harness powerful nanotechnology to transform our understanding and treatment of rare diseases, cancer, and infectious diseases. Leading academic institutions, pharmaceutical […]